Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026)

Emergent BioSolutions' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.51 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 5.07% year-over-year to 0.51 in Q1 2026; TTM through Mar 2026 was 0.51, a 5.07% decrease from a year earlier, with the FY2025 full-year figure at 0.55, down 15.55% from the prior year.
• Asset Utilization Ratio eased to 0.51 in Q1 2026 per EBS's latest filing, from 0.53 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.65 in Q1 2024 and bottomed at 0.32 in Q1 2023.
• The 5-year median for Asset Utilization Ratio is 0.54 (2023), against an average of 0.53.
• Across the five-year window, Asset Utilization Ratio sank 46.13% in 2023 and soared 104.61% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.37 in 2022, then soared by 53.16% to 0.56 in 2023, then grew by 3.61% to 0.59 in 2024, then slipped by 8.64% to 0.53 in 2025, then fell by 4.04% to 0.51 in 2026.
• Per Business Quant, the three latest EBS Asset Utilization Ratio figures stand at 0.51 (Q1 2026), 0.53 (Q4 2025), and 0.55 (Q3 2025).